These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 534582

  • 1. Comparison of haemodynamic effects of oral hydralazine and prazosin hydrochloride in patients with chronic congestive heart failure.
    Chatterjee K, Ports TA, Arnold S, Brundage B, Parmley W.
    Br Heart J; 1979 Dec; 42(6):657-63. PubMed ID: 534582
    [Abstract] [Full Text] [Related]

  • 2. Comparison of haemodynamic effects of oral prazosin, oral hydralazine, and intravenous nitroprusside in same patients with chronic heart failure.
    Mehta J, Iacona M, Pepine CJ, Conti CR.
    Br Heart J; 1979 Dec; 42(6):664-70. PubMed ID: 534583
    [Abstract] [Full Text] [Related]

  • 3. Prazosin and hydralazine in congestive heart failure. Regional hemodynamic effects in relation to dose.
    Magorien RD, Triffon DW, Desch CE, Bay WH, Unverferth DV, Leier CV.
    Ann Intern Med; 1981 Jul; 95(1):5-13. PubMed ID: 7247126
    [Abstract] [Full Text] [Related]

  • 4. Sustained reduction of cardiac impedance and preload in congestive heart failure with the antihypertensive vasodilator prazosin.
    Miller RR, Awan NA, Maxwell KS, Mason DT.
    N Engl J Med; 1977 Aug 11; 297(6):303-7. PubMed ID: 889599
    [Abstract] [Full Text] [Related]

  • 5. Afterload reduction and cardiac performance. Physiologic basis of systemic vasodilators as a new approach in treatment of congestive heart failure.
    Mason DT.
    Am J Med; 1978 Jul 11; 65(1):106-25. PubMed ID: 99030
    [Abstract] [Full Text] [Related]

  • 6. Dynamic responses to continuous use of prazosin and hydralazine in patients with refractory heart failure.
    Elkayam U, Mathur M, Frishman W, LeJemtel T, Strom J, Sonnenblick EH.
    Clin Pharmacol Ther; 1981 Jul 11; 30(1):23-30. PubMed ID: 7237894
    [Abstract] [Full Text] [Related]

  • 7. Acute haemodynamic effects of oral prazosin in severe mitral regurgitation.
    Mehta J, Feldman RL, Nichols WW, Pepine CJ, Conti CR.
    Br Heart J; 1980 May 11; 43(5):556-60. PubMed ID: 7378216
    [Abstract] [Full Text] [Related]

  • 8. Attenuation of prazosin effect on cardiac output in chronic heart failure.
    Arnold SB, Williams RL, Ports TA, Baughman RA, Benet LZ, Parmley WW, Chatterjee K.
    Ann Intern Med; 1979 Sep 11; 91(3):345-9. PubMed ID: 475164
    [Abstract] [Full Text] [Related]

  • 9. Effect of vasodilator drugs on exercise performance in cardiac failure. Comparison of hydralazine and prazosin.
    Fitchett DH, Pathé M, Pardy R, Despas P.
    Br Heart J; 1980 Aug 11; 44(2):215-20. PubMed ID: 7426176
    [No Abstract] [Full Text] [Related]

  • 10. Oral hydralazine in chronic heart failure: sustained beneficial hemodynamic effects.
    Chatterjee K, Ports TA, Brundage BH, Massie B, Holly AN, Parmley WW.
    Ann Intern Med; 1980 May 11; 92(5):600-4. PubMed ID: 7386999
    [Abstract] [Full Text] [Related]

  • 11. Differences in hemodynamic effects of nitroprusside and prazosin in severe chronic congestive heart failure: evidence for a direct negative chronotropic effect of prazosin.
    Packer M, Meller J, Gorlin R, Herman MV.
    Am J Cardiol; 1979 Aug 11; 44(2):310-7. PubMed ID: 463769
    [Abstract] [Full Text] [Related]

  • 12. The acute and chronic haemodynamic effects of prazosin in severe congestive cardiac failure.
    Harper RW, Claxton H, Middlebrook K, Anderson S, Pitt A.
    Med J Aust; 1980 Jul 26; 2(SP1):36-8. PubMed ID: 7421721
    [No Abstract] [Full Text] [Related]

  • 13. Vasodilators and ventricular septal defect: comparison of prazosin, minoxidil, and hydralazine in a chronic lamb model.
    Boucek MM, Chang R, Synhorst DP.
    Pediatr Res; 1984 Sep 26; 18(9):859-64. PubMed ID: 6483509
    [Abstract] [Full Text] [Related]

  • 14. Haemodynamic effects of a single low dose of prazosin in patients with chronic congestive cardiac failure correlations with pharmacokinetics.
    Horowitz JD, Dynon MK, Jarrott B, Brennan JB, Oliver LE, Goble AJ, Louis WJ.
    Clin Exp Pharmacol Physiol; 1984 Sep 26; 11(1):7-15. PubMed ID: 6713738
    [Abstract] [Full Text] [Related]

  • 15. Haemodynamic effects of hydralazine at rest and during exercise in patients with chronic heart failure.
    Ginks WR, Redwood DR.
    Br Heart J; 1980 Sep 26; 44(3):259-64. PubMed ID: 7426183
    [Abstract] [Full Text] [Related]

  • 16. Effectiveness of long-term vasodilator administration in the treatment of chronic left ventricular failure.
    Franciosa JA.
    Prog Cardiovasc Dis; 1982 Sep 26; 24(4):319-30. PubMed ID: 7034048
    [No Abstract] [Full Text] [Related]

  • 17. Comparative haemodynamic effects of intravenous nisoldipine and hydralazine in congestive heart failure.
    Haitas B, Meyer TE, Angel ME, Reef E.
    Br J Clin Pharmacol; 1990 Mar 26; 29(3):366-8. PubMed ID: 2310661
    [Abstract] [Full Text] [Related]

  • 18. Acute and chronic haemodynamic effects of prazosin in left ventricular failure.
    Stein L, Foster PR, Friedman AW, Statza J, McHenry PL.
    Br Heart J; 1981 Feb 26; 45(2):186-92. PubMed ID: 7459177
    [Abstract] [Full Text] [Related]

  • 19. Contrasting hemodynamic responses in severe heart failure: comparison of captopril and other vasodilator drugs.
    Packer M, Medina N, Yushak M.
    Am Heart J; 1982 Nov 26; 104(5 Pt 2):1215-23. PubMed ID: 6753552
    [Abstract] [Full Text] [Related]

  • 20. Long-term outpatient vasodilator therapy of congestive heart failure. Consideration of agents at rest and during exercise.
    Chatterjee K, Massie B, Rubin S, Gelberg H, Brundage BH, Ports TA.
    Am J Med; 1978 Jul 26; 65(1):134-45. PubMed ID: 99031
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.